NCT02108626

Brief Summary

The aim of this study is to measure nicotine cue- and withdrawal-induced craving in current smokers under four distinct conditions: after smoking a conventional cigarette, an electronic cigarette (e-Cigarette) containing nicotine, an e-Cigarette without nicotine, and after taking a nicotine lozenge. Participants will be asked to attend four morning study visits after overnight smoking abstinence. Standardized questionnaires will be used to assess changes under each condition, allowing for the investigation of the efficacy of e-Cigarettes in reducing craving by replacing the behavioral component of smoking with minimal risk of adverse effects.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
43

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Mar 2014

Shorter than P25 for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2014

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

April 7, 2014

Completed
2 days until next milestone

First Posted

Study publicly available on registry

April 9, 2014

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2015

Completed
Last Updated

May 5, 2015

Status Verified

May 1, 2015

Enrollment Period

1.1 years

First QC Date

April 7, 2014

Last Update Submit

May 4, 2015

Conditions

Keywords

Electronic CigarettesLozengeNicotineTobaccoDependenceWithdrawal

Outcome Measures

Primary Outcomes (1)

  • Cue-induced nicotine craving

    Craving assessment after presentation of smoking- and neutral-cues 1 hour after condition

    1 hour after condition

Secondary Outcomes (1)

  • Withdrawal-induced nicotine craving

    3 hours after condition

Study Arms (2)

E-Cigarette with nicotine

ACTIVE COMPARATOR

Electronic cigarette with cartridge fluid containing nicotine

Drug: Nicotine

E-Cigarette without nicotine

PLACEBO COMPARATOR

Electronic cigarette with cartridge fluid containing no nicotine (placebo)

Drug: Placebo

Interventions

E-Cigarette with nicotine cartridge

E-Cigarette with nicotine

E-Cigarette with 0mg nicotine cartridge

E-Cigarette without nicotine

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Current daily smoker
  • Smoke minimum of 10 cigarettes per day
  • Fagerstrom Test of Nicotine Dependence Score equal or greater than 3
  • Never used an e-Cigarette prior to the study
  • No intention to quit smoking within the next 3 months
  • Able to provide written informed consent
  • Able and willing to attend scheduled appointments

You may not qualify if:

  • Any serious medical or unstable psychiatric problems requiring treatment
  • Pregnancy or lactation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre for Addiction and Mental Health, BACDRL Lab

Toronto, Ontario, M5S 2S1, Canada

Location

Related Publications (1)

  • Ng G, Attwells S, Selby P, Zawertailo L. Effectiveness of Non-Nicotinic E-Cigarettes to Reduce Cue- and Abstinence-Induced Cigarette Craving in Non-Treatment Seeking Daily Dependent Smokers. Psychopharmacology (Berl). 2021 Jun;238(6):1461-1472. doi: 10.1007/s00213-021-05772-4. Epub 2021 Jan 30.

Related Links

MeSH Terms

Conditions

Substance Withdrawal SyndromeTobacco Use DisorderVaping

Interventions

Nicotine

Condition Hierarchy (Ancestors)

Substance-Related DisordersChemically-Induced DisordersMental DisordersSmokingBehavior

Intervention Hierarchy (Ancestors)

Solanaceous AlkaloidsAlkaloidsHeterocyclic CompoundsPyridinesHeterocyclic Compounds, 1-Ring

Study Officials

  • Laurie Zawertailo, PhD

    Centre for Addiction and Mental Health

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Independent Scientist

Study Record Dates

First Submitted

April 7, 2014

First Posted

April 9, 2014

Study Start

March 1, 2014

Primary Completion

April 1, 2015

Study Completion

April 1, 2015

Last Updated

May 5, 2015

Record last verified: 2015-05

Locations